CATCH UP ON DEMAND
Pharma Integrates 2022 – Bringing together pharma and healthcare leaders across the Pharmaceutical pipeline
Click here for Track 1, Click here for Track 2, Click here for Track 3
Advanced Therapies Integrates 2022 – In partnership with Cell and Gene Therapy Catapult
Click here for Track 1, Click here for Track 2, Click here for Track 3
PharmaTech Integrates 2022 – In partnership with Medicines Manufacturing Innovation Centre
Click here for Track 1, Click here for Track 2, Click here for Track 3
MedTech Integrates 2022
All sessions now available on-demand!
Click here for Track 1, Click here for Track 2, Click here for Track 3
Bio Integrates 2022 – Engage with the community transforming the biotech sector
Click here for Track 1, Click here for Track 2, Click here for Track 3
Pharma Sustainability Integrates 2022 – Focused on pharma leaders and policy makers
Click here for Track 1
Our Q&A Series
3 questions with…Brian Mullan
3 questions with…
BRIAN MULLAN
Chief Technical Officer, Cell and Gene Therapies
Yposkesi
3 questions with…Freddie Dear
3 questions with…
FREDDIE DEAR
Head of Corporate Development & Portfolio Manager
Ascend Gene and Cell Therapies
3 Questions with… Bill Scott
3 questions with…
BILL SCOTT
Scientific Director
Transplant Regenerative Medicine
Newcastle University Medical School
3 Questions with… Ian Anderson
3 questions with…
IAN ANDERSON
Global Senior Principal Scientist,
Global Biologics
Lonza
3 Questions with… Antoine Espinet
3 questions with…
ANTOINE ESPINET
Co Founder & Chief Executive Officer
MicrofluidX
3 Questions with… Mustafa Munye
3 questions with…
MUSTAFA MUNYE
Director of R&D Operations
Complement Therapeutics
3 questions with… Jason Mellad
3 questions with…
JASON MELLAD
Chief Executive Officer
Start Codon
3 questions with… Moin Saleem
3 questions with…
Moin Saleem
Professor of Paediatric Renal Medicine
University of Bristol
Co-Founder of Purespring Therapeutics
LATEST NEWS
How to secure VC funding in a challenging economic climate
Our Consultant Lewis Aweyo attended the “VC judges: what is the X factor?” panel discussion at Advanced Therapies Integrates on 20th October.
Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022
As the chancellor stood outside Downing Street to deliver the Autumn Statement, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event.
Accelerating advanced therapies to market
Translating discoveries from an idea in the laboratory to a drug or final product that is fit for patients can be challenging. How can we progress advanced therapies through the clinical phase of development?
MOST POPULAR READS
LIFE SCIENCE INTEGRATES INDUSTRY INSIGHTS
Treatment
READ MORE | 5 Minute Read
Technology
READ MORE | 7 minute read
Talent
READ MORE | 5 Minute Read
Tactics
READ MORE | 5 Minute Read
Considering The Patient
READ MORE | 5 Minute Read
Catapults
READ MORE | 5 Minute Read
MARCO MOHWINCKEL INSIGHTS
Marco Mohwinckel: Revolutionising Drug Discover With Big Data And AI
READ MORE | 10 Minute Read
Marco Mohwinckel:
Backend and Buzzing:
Blockchain
READ MORE | 20 Minute Read
Marco Mohwinckel:
The Disruptive Power
of Pharma AI
READ MORE | 10 Minute Read
VISIT OUR INSIGHTS AREAS
WHITE PAPERS
EFFECTIVE AND FAST APPROVAL OF INCIDENT INVESTIGATION REPORTS
Deviations, incidents or investigations – whatever you call them – require an efficient and effective system for review and approval.
DRUG SHORTAGES WHY DO THEY HAPPEN AND HOW CAN WE STOP THEM?
With 56% of U.S. health care providers reporting to have changed patient care or delayed therapy as a result of drug shortages, John Johnson looks at the key reasons behind the issue and what you can do to stop it.
MANAGING A QUALITY SYSTEM WITH A 50% STAFF REDUCTION
Imagine you are the Quality Director of a site manufacturing critical medicinal products or medical devices. You have a sickness absence rate of 50% of QA and QC staff. What do you do?
LATEST NEWS
How to secure VC funding in a challenging economic climate
Our Consultant Lewis Aweyo attended the “VC judges: what is the X factor?” panel discussion at Advanced Therapies Integrates on 20th October.
Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022
As the chancellor stood outside Downing Street to deliver the Autumn Statement, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event.
Accelerating advanced therapies to market
Translating discoveries from an idea in the laboratory to a drug or final product that is fit for patients can be challenging. How can we progress advanced therapies through the clinical phase of development?
INDUSTRY INSIGHTS
Treatment
A key part of Pharma Integrates’ agenda revolved around the efficacy of different types of treatment, how to get therapies to patients quickly and effectively, the impact of personalised medicine, technological advances in drug discovery and tackling rare diseases.
Technology
With investment in the digital health sector reaching a record $8.1bn (£6.2bn) in 2018 and with one third of all US healthcare investment now in digital health technology, it is becoming increasingly important that the life sciences sector keeps up to date with the latest technological advances.
Talent
A company’s staff is its greatest asset, but with every business struggling to recruit and retain key talent, and with the very real threat of a Brexit “brain drain”, how can the life sciences industry attract the best and brightest?
Tactics
In an ever-changing pharmaceutical industry, both in terms of innovation and R&D, as well as from a business and funding perspective, the subject of strategic development and tactics to boost productivity was firmly on the agenda at November’s Pharma Integrates.
ON TWITTER
WHITE PAPERS
EFFECTIVE AND FAST APPROVAL OF INCIDENT INVESTIGATION REPORTS
Deviations, incidents or investigations – whatever you call them – require an efficient and effective system for review and approval.
DRUG SHORTAGES WHY DO THEY HAPPEN AND HOW CAN WE STOP THEM?
With 56% of U.S. health care providers reporting to have changed patient care or delayed therapy as a result of drug shortages, John Johnson looks at the key reasons behind the issue and what you can do to stop it.
MANAGING A QUALITY SYSTEM WITH A 50% STAFF REDUCTION
Imagine you are the Quality Director of a site manufacturing critical medicinal products or medical devices. You have a sickness absence rate of 50% of QA and QC staff. What do you do?
LATEST NEWS
How to secure VC funding in a challenging economic climate
Our Consultant Lewis Aweyo attended the “VC judges: what is the X factor?” panel discussion at Advanced Therapies Integrates on 20th October.
Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022
As the chancellor stood outside Downing Street to deliver the Autumn Statement, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event.
Accelerating advanced therapies to market
Translating discoveries from an idea in the laboratory to a drug or final product that is fit for patients can be challenging. How can we progress advanced therapies through the clinical phase of development?
INDUSTRY INSIGHTS
Treatment
A key part of Pharma Integrates’ agenda revolved around the efficacy of different types of treatment, how to get therapies to patients quickly and effectively, the impact of personalised medicine, technological advances in drug discovery and tackling rare diseases.
Technology
With investment in the digital health sector reaching a record $8.1bn (£6.2bn) in 2018 and with one third of all US healthcare investment now in digital health technology, it is becoming increasingly important that the life sciences sector keeps up to date with the latest technological advances.
Talent
A company’s staff is its greatest asset, but with every business struggling to recruit and retain key talent, and with the very real threat of a Brexit “brain drain”, how can the life sciences industry attract the best and brightest?
Tactics
In an ever-changing pharmaceutical industry, both in terms of innovation and R&D, as well as from a business and funding perspective, the subject of strategic development and tactics to boost productivity was firmly on the agenda at November’s Pharma Integrates.
ON TWITTER
PREVIOUS EVENTS
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.